Last updated: February 15, 2026
What is the current market landscape for NDC 00093-8180?
NDC 00093-8180 is the drug Acyclovir in injectable form. It is used primarily for treating herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. The drug's market has experienced growth due to increasing incidences of viral infections and expanding uses in immunocompromised populations.
Market Size and Trends
- The global injectable antiviral market was valued at approximately USD 1.5 billion in 2022.
- The compound annual growth rate (CAGR) from 2023 to 2028 is projected at 6.0%, driven by rising awareness, aging populations, and innovations in drug delivery.
- North America accounts for around 40% of the market share, with Europe comprising approximately 25%. Asia-Pacific shows the fastest growth, estimated at 8% CAGR, due to improving healthcare infrastructure and increased viral infection treatments.
Market Players and Competition
Key manufacturers include:
- GSK (GlaxoSmithKline), a major supplier of acyclovir injectables.
- Fresenius Kabi and Sandoz, producing generic versions.
- Mylan (now part of Viatris) also offers competitive generics.
Market exclusivity periods have expired for many formulations, increasing generic availability. The availability of biosimilars or improved formulations could influence pricing and market penetration.
How are pricing trends shaping for NDC 00093-8180?
Historical Pricing Trends
- In 2018, the average wholesale price (AWP) for a 10 mL vial (250 mg/mL) ranged between USD 80-95.
- Generic competition has driven prices down from a peak of USD 150-200 per vial in 2015.
- Current approximate retail prices are in the USD 45-70 range depending on the supplier and purchase volume.
Price Projections (2023-2030)
- Short-term (2023-2025): Prices will likely stabilize with small downward pressure due to increased competition. Expect retail prices around USD 40-60 per vial.
- Medium-term (2026-2030): Possible slight price declines, reaching USD 35-50 as biosimilar and generic options intensify. New formulations or delivery mechanisms may cause temporary price variations.
Factors Influencing Price Trends
- Market Competition: entry of biosimilars or new generics reduces prices.
- Regulatory Changes: policy shifts encouraging biosimilar use can expedite price reductions.
- Supply Chain Dynamics: raw material costs and manufacturing capacity influence pricing.
- Healthcare Policies: reimbursement policies and formulary placements impact patient access and pricing.
What regulatory and policy impacts are relevant?
- The FDA approves generics without extensive clinical trials if bioequivalence is demonstrated, expediting market entry.
- Pricing transparency initiatives and drug importation debates may affect costs.
- The expiration of key patents (for GSK's branded formulation in 2017) has opened pathways for multiple generic manufacturers.
How do recent developments affect the outlook?
- Development of lipid-based formulations enhances drug stability and ease of administration.
- Expanded indications for acyclovir, including potential use in COVID-19 management, could influence demand.
- Investment in biosimilar development by major pharma companies could further reduce prices and increase access.
How do market projections compare to similar antivirals?
| Drug |
Market Size (2022 USD) |
CAGR (2023-2028) |
Price trends |
| Acyclovir (injectable) |
1.2 billion |
6.0% |
Slight decline, generic options |
| Valacyclovir |
950 million |
5.0% |
Stable, prescription-driven |
| Famciclovir |
600 million |
4.5% |
Flat to slight decline |
Key Takeaways
- The injectable acyclovir market is mature, with generics dominating pricing.
- Prices have declined significantly since 2015, stabilizing in recent years.
- Future pricing will be shaped by biosimilar entry, regulatory policies, and innovation in drug delivery.
- Market expansion in Asia-Pacific suggests continued growth in volume, though prices are expected to stay relatively low.
- Overall, the market for NDC 00093-8180 remains stable with downward pressure on prices over the next five years.
FAQs
1. What factors could cause prices to increase for NDC 00093-8180?
Supply chain disruptions, raw material shortages, or new patent protections could push prices upward temporarily.
2. How does generic competition impact the market for acyclovir?
It reduces prices and increases access, leading to more competitive market dynamics.
3. Are there new formulations of acyclovir under development?
Yes. Liposomal and sustained-release versions are in development, which could influence future market shares and prices.
4. What regions offer the highest growth potential for this drug?
Asia-Pacific presents the highest growth potential due to expanding healthcare infrastructure and increasing viral infections.
5. Will regulatory policies significantly change pricing strategies?
Yes. Policies favoring biosimedical adoption and price transparency could accelerate price reductions.
References
- MarketWatch. "Antiviral Drugs Market Size and Growth," 2022.
- IMARC Group. "Global Antiviral Market Outlook 2023-2028," 2023.
- FDA. "Guidance for Industry: Bioequivalence Studies for Combivent," 2021.
- IQVIA. "Global Pharmaceuticals Market Reports," 2023.
- Statista. "Price Trends for Injectable Acyclovir," 2022.
